Author

Liv Tybjærg Nordestgaard

University of BristolORCID 0000-0002-5490-0034Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Dylan M. WilliamsiD· 1 shared Emma Louise AndersoniD· 1 shared Neil M DaviesiD· 1 shared Patrick G. KehoeiD· 1 shared Phazha LK BothongoiD· 1 shared Venexia M. WalkeriD· 1 shared Victoria Taylor‐BatemaniD· 1 shared Yoav Ben‐ShlomoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Dylan M. WilliamsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repurposing drugs for the prevention of vascular dementia: Evidence from drug target Mendelian randomization

Victoria Taylor‐Bateman, Phazha LK Bothongo, Venexia M. Walker, Patrick G. Kehoe, Liv Tybjærg Nordestgaard, Yoav Ben‐Shlomo, Neil M Davies, Dylan M. Williams, Emma Louise Anderson

This paper uses Mendelian randomization to assess if existing drugs targeting lipid-lowering, anti-hypertensive, or anti-inflammatory pathways affect vascular dementia risk, finding potential benefits for beta-1 adrenergic receptor antagonists and risks for ACE inhibitors.

medRxiv · Apr 11, 2025 · PreprintGenetic & Genomic Medicine